VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $219,604 | -0.2% | 7,662 | -16.1% | 0.03% | -12.1% |
| Q3 2022 | $220,000 | -14.4% | 9,135 | -2.6% | 0.03% | -10.8% |
| Q2 2022 | $257,000 | -34.8% | 9,381 | -8.6% | 0.04% | -32.7% |
| Q1 2022 | $394,000 | +9.1% | 10,269 | -8.9% | 0.06% | +7.8% |
| Q4 2021 | $361,000 | -71.7% | 11,269 | -74.0% | 0.05% | -74.1% |
| Q3 2021 | $1,275,000 | +75.9% | 43,271 | +102.7% | 0.20% | +71.3% |
| Q2 2021 | $725,000 | -11.0% | 21,349 | -14.8% | 0.12% | -22.8% |
| Q1 2021 | $815,000 | -10.6% | 25,068 | -1.0% | 0.15% | -11.8% |
| Q4 2020 | $912,000 | -3.5% | 25,318 | +4.9% | 0.17% | -23.9% |
| Q3 2020 | $945,000 | +74.0% | 24,137 | +63.1% | 0.22% | +57.4% |
| Q2 2020 | $543,000 | +120.7% | 14,800 | +38.7% | 0.14% | +85.5% |
| Q1 2020 | $246,000 | – | 10,667 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |